LLY Stock: Should You Buy After A 20% Rise?
We believe there is minimal cause for concern with LLY stock, which makes it attractive but highly sensitive to adverse ...
Eli Lilly's first weight loss pill could expand access to GLP-1s around the globe, executive says
Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
BioPharma Dive16d
Lilly expands US manufacturing build-out with $50B target
The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...
Eli Lilly comes for knockoff weight loss drugs in new ad campaign
Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, launched a new advertising campaign on Friday ...
Pharmacy firm cuts prices for popular weight-loss drug again
Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...
Hosted on MSN22d
Eli Lilly wants to use its weight loss drug windfall to fight Alzheimer's and hearing loss
Medical bottles and syringe are seen with Eli Lilly and Company logo displayed on a screen in the background in this illustration photo taken in Krakow, Poland on November 10, 2022. The weight ...